Manchester Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $451K | Buy |
1,528
+256
| +20% | +$76K | 0.07% | 175 |
|
|
2025
Q4 | $347K | Sell |
1,272
-73
| -5% | -$19.8K | 0.05% | 214 |
|
|
2025
Q3 | $363K | Sell |
1,345
-7
| -0.5% | -$1.91K | 0.05% | 237 |
|
|
2025
Q2 | $373K | Sell |
1,352
-146
| -10% | -$39.7K | 0.05% | 258 |
|
|
2025
Q1 | $397K | Buy |
1,498
+188
| +14% | +$46.4K | 0.05% | 238 |
|
|
2024
Q4 | $304K | Hold |
1,310
| – | – | 0.04% | 282 |
|
|
2024
Q3 | $289K | Buy |
1,310
+135
| +11% | +$27.9K | 0.03% | 287 |
|
|
2024
Q2 | $231K | Sell |
1,175
-152
| -11% | -$31.4K | 0.03% | 294 |
|
|
2024
Q1 | $286K | Buy |
1,327
+240
| +22% | +$50.4K | 0.04% | 270 |
|
|
2023
Q4 | $229K | Buy |
1,087
+46
| +4% | +$9.81K | 0.03% | 268 |
|
|
2023
Q3 | $208K | Buy |
1,041
+2
| +0.2% | +$398 | 0.03% | 260 |
|
|
2023
Q2 | $193K | Sell |
1,039
-91
| -8% | -$16.8K | 0.03% | 276 |
|
|
2023
Q1 | $216K | Buy |
1,130
+96
| +9% | +$17.4K | 0.03% | 278 |
|
|
2022
Q4 | $174K | Sell |
1,034
-7
| -0.7% | -$1.22K | 0.03% | 261 |
|
|
2022
Q3 | $184K | Sell |
1,041
-2
| -0.2% | -$395 | 0.03% | 219 |
|
|
2022
Q2 | $214K | Sell |
1,043
-12
| -1% | -$2.54K | 0.04% | 208 |
|
|
2022
Q1 | $251K | Buy |
1,055
+10
| +1% | +$2.35K | 0.04% | 229 |
|
|
2021
Q4 | $239K | Buy |
1,045
+2
| +0.2% | +$440 | 0.03% | 247 |
|
|
2021
Q3 | $202K | Buy |
1,043
+22
| +2% | +$4.46K | 0.03% | 276 |
|
|
2021
Q2 | $217K | Hold |
1,021
| – | – | 0.03% | 256 |
|
|
2021
Q1 | $209K | Hold |
1,021
| – | – | 0.03% | 255 |
|
|
2020
Q4 | $186K | Buy |
1,021
+86
| +9% | +$14.6K | 0.03% | 247 |
|
|
2020
Q3 | $156K | Sell |
935
-775
| -45% | -$131K | 0.02% | 236 |
|
|
2020
Q2 | $278K | Hold |
1,710
| – | – | 0.04% | 204 |
|
|
2020
Q1 | $296K | Hold |
1,710
| – | – | 0.05% | 183 |
|
|
2019
Q4 | $343K | Hold |
1,710
| – | – | 0.04% | 200 |
|
|
2019
Q3 | $361K | Sell |
1,710
-100
| -6% | -$20.9K | 0.04% | 182 |
|
|
2019
Q2 | $351K | Hold |
1,810
| – | – | 0.05% | 185 |
|
|
2019
Q1 | $298K | Hold |
1,810
| – | – | 0.04% | 194 |
|
|
2018
Q4 | $297K | Hold |
1,810
| – | – | 0.05% | 179 |
|
|
2018
Q3 | $308K | Hold |
1,810
| – | – | 0.04% | 184 |
|
|
2018
Q2 | $297K | Hold |
1,810
| – | – | 0.05% | 181 |
|
|
2018
Q1 | $293K | Buy |
1,810
+100
| +6% | +$15.9K | 0.05% | 171 |
|
|
2017
Q4 | $250K | Hold |
1,710
| – | – | 0.04% | 176 |
|
|
2017
Q3 | $232K | Hold |
1,710
| – | – | 0.04% | 166 |
|
|
2017
Q2 | $214K | Hold |
1,710
| – | – | 0.03% | 182 |
|
|
2017
Q1 | $203K | Hold |
1,710
| – | – | 0.03% | 181 |
|
|
2016
Q4 | $197K | Hold |
1,710
| – | – | 0.03% | 179 |
|
|
2016
Q3 | $179K | Hold |
1,710
| – | – | 0.03% | 204 |
|
|
2016
Q2 | $167K | Hold |
1,710
| – | – | 0.02% | 216 |
|
|
2016
Q1 | $164K | Hold |
1,710
| – | – | 0.02% | 220 |
|
|
2015
Q4 | $155K | Hold |
1,710
| – | – | 0.02% | 245 |
|
|
2015
Q3 | $159K | Hold |
1,710
| – | – | 0.03% | 228 |
|
|
2015
Q2 | $159K | Hold |
1,710
| – | – | 0.03% | 234 |
|
|
2015
Q1 | $161K | Sell |
1,710
-262
| -13% | -$24.3K | 0.03% | 223 |
|
|
2014
Q4 | $175K | Hold |
1,972
| – | – | 0.02% | 400 |
|
|
2014
Q3 | $158K | Hold |
1,972
| – | – | 0.02% | 424 |
|
|
2014
Q2 | $140K | Hold |
1,972
| – | – | 0.02% | 470 |
|
|
2014
Q1 | $146K | Hold |
1,972
| – | – | 0.02% | 421 |
|
|
2013
Q4 | $155K | Hold |
1,972
| – | – | 0.02% | 388 |
|
|
2013
Q3 | $146K | Hold |
1,972
| – | – | 0.03% | 395 |
|
|
2013
Q2 | $150K | Buy |
+1,972
| New | +$129K | 0.03% | 377 |
|
Other funds holding CME
VCM
VPM
Manchester Capital Management's CME Position: Q1 2026 in Review
Manchester Capital Management increased its CME Group (CME) stake by 20% in Q1 2026, buying an estimated $76K and bringing the position to 1,528 shares worth $451K. The position accounts for 0.07% of the portfolio, ranked #175.
Manchester Capital Management first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Manchester Capital Management held 1,528 shares of CME Group worth $451K as of Q1 2026.
- Manchester Capital Management bought 256 CME Group shares in Q1 2026, an estimated $76K.
- CME Group made up 0.07% of Manchester Capital Management's portfolio in Q1 2026, its #175 holding.
- Manchester Capital Management first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.